News

The Reprove trial evaluated the efficacy of Zavicefta compared to meropenem in the treatment of adult patients with hospital-acquired pneumonia, including ventilator-associated pneumonia. The antibiotic met the primary

Apex’s lead drug candidate APX3330 is a small molecule that targets the redox effector factor-1 (Ref-1) protein which regulates the activation of oncogenic transcription factors. The first part

In conjunction with the financing, Andrew Levin, M.D., Ph.D., managing director of RA Capital Management, will join Synthorx’s board of directors. Leveraging a synthetic biology breakthrough, Synthorx has

Under the terms of the agreement, Sapience will gain exclusive rights to the development and commercialization of intellectual property developed at Columbia University by Drs. Lloyd Greene and

West-Ward's Capecitabine Tablets are indicated for adjuvant treatment in patients with Dukes' C colon cancer, as monotherapy in metastatic colorectal cancer, and in combination with docetaxel or as

Under the terms of the agreement, PeptiDream will receive an undisclosed upfront payment, annual technology access payments, and is eligible to receive payments based on achievement of certain

CHI refers to several congenital disorders in which hypoglycemia is caused by excessive insulin secretion. Itis a rare genetic disorder in which the insulin cells of the pancreas

The equity stake is part of an agreement under which Shire granted three central nervous system (CNS) pre-clinical development programs to Chronos in return for milestones and an

Fast Track designation is granted by FDA to drugs that are under development for serious conditions and have the potential to fulfill an unmet medical need. It was